ClinicalTrials.gg
Not yet recruitingNCT07883733Updated Oct 20, 2026

Comparing Spinal, Epidural, and Dural Puncture Epidural Anesthesia for Cesarean Delivery: Hemodynamics and Block Quality

An interventional study of Spinal Anesthesia and Epidural Anesthesia in Hypotension After Neuraxial Anesthesia, Cesarean Section and Anesthesia, Obstetrical, sponsored by Bursa Yuksek Ihtisas Training and Research Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Bursa Yuksek Ihtisas Training and Research Hospital · Not applicable, Interventional, and Supportive care

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this clinical trial is to compare three regional anesthesia techniques (spinal, epidural, and dural puncture epidural anesthesia) in healthy pregnant women undergoing planned (elective) cesarean delivery. The main questions it aims to answer are:

Which technique causes less low blood pressure (maternal hypotension) and requires less vasopressor medication during surgery? Which technique provides faster and more effective surgical anesthesia?

Spinal anesthesia works quickly but often causes a sudden drop in blood pressure, while epidural anesthesia is more stable but slower and sometimes incomplete. Dural puncture epidural is a newer technique that may combine the speed of spinal anesthesia with the stability of epidural anesthesia.

A total of 120 participants will be randomly assigned in equal numbers to one of the three groups. Researchers will compare the groups for blood pressure and heart rate changes, number of hypotension episodes, vasopressor use, time to reach adequate block (T6 level), block quality, need for additional pain medication, and side effects such as nausea, vomiting, and headache. Newborn well-being will be assessed with Apgar scores and umbilical cord blood gas analysis. Maternal and surgeon satisfaction will also be recorded.

Read the detailed description

Background: Spinal anesthesia is the most commonly used technique for cesarean delivery and provides a rapid, dense block; however, the sudden sympathetic blockade leads to maternal hypotension in up to 70-80% of cases, which may reduce uteroplacental blood flow and compromise the fetus. Conventional epidural anesthesia offers greater hemodynamic stability but has a slower onset and may result in patchy or inadequate block. The dural puncture epidural (DPE) technique, in which the dura is punctured with a spinal needle without intrathecal drug injection before epidural catheter placement, may facilitate translocation of epidural drugs into the intrathecal space, potentially combining a faster onset with hemodynamic stability. Existing studies show considerable methodological heterogeneity, and few trials have compared all three techniques simultaneously under a standardized protocol.

Design: This is a single-center, prospective, randomized controlled trial with three parallel arms. After written informed consent, 120 parturients scheduled for elective cesarean delivery will be randomized in a 1:1:1 ratio using a computer-generated sequence and sequentially numbered sealed envelopes on the morning of surgery to one of the following groups:

  • Group S (Spinal): Intrathecal 10 mg 0.5% hyperbaric bupivacaine + 10 mcg fentanyl.
  • Group E (Epidural): Epidural catheter placement followed by a test dose and 15-20 mL of local anesthetic solution (10 mL 0.5% isobaric bupivacaine + 50 mcg fentanyl + 5 mL 2% lidocaine + 4 mL normal saline).
  • Group DPE (Dural Puncture Epidural): Dural puncture with a 27G atraumatic spinal needle without intrathecal drug administration, followed by epidural catheter placement, test dose, and the same epidural solution as Group E.

In Groups E and DPE, if bilateral T6 sensory block is not achieved within 10 minutes, 5 mL of 0.25% bupivacaine will be administered every 5 minutes up to a cumulative maximum of 30 mL. Patients who fail to achieve adequate block or require conversion to general anesthesia will be excluded from the study.

All blocks will be performed by an experienced anesthesiologist not involved in data collection. All patients will receive standardized intravenous hydration.

Measurements: Baseline values will be recorded before the neuraxial block. Non-invasive blood pressure, heart rate (ECG), and SpO2 will be recorded every 3 minutes for the first 20 minutes after completion of the block and every 5 minutes thereafter until the end of surgery. Shock index (heart rate / systolic blood pressure) and diastolic shock index (heart rate / diastolic blood pressure) will be calculated. Hypotension is defined as a decrease in mean arterial pressure of more than 20% from baseline or systolic blood pressure below 90 mmHg and will be treated with intravenous ephedrine boluses; bradycardia is defined as heart rate below 50 beats/min and will be treated with atropine. Sensory block will be assessed bilaterally with pin-prick and cold tests, and motor block with the modified Bromage scale. Neonatal outcomes will be assessed with 1- and 5-minute Apgar scores and umbilical cord blood gas analysis. Maternal satisfaction, side effects, and post-dural puncture headache will be evaluated at the postoperative 24-hour visit. Patients will also be contacted by telephone on postoperative day 3 to assess post-dural puncture headache.

Sample size: Based on an expected hypotension incidence of 65% after spinal anesthesia and 30% after epidural and DPE techniques, a sample size of 34 patients per group was calculated (effect size w = 0.33, α = 0.05, power = 80%, G*Power 3.1.9.7). Allowing for a 15% dropout rate, 40 patients per group (120 in total) will be enrolled.

Statistical analysis: Data will be analyzed using SPSS v26.0. Normality will be assessed with the Shapiro-Wilk test. Normally distributed data will be presented as mean ± standard deviation, and non-normally distributed or ordinal data as median (minimum-maximum). One-way ANOVA or Kruskal-Wallis tests will be used to compare the three groups, followed by Tukey or Dunn post-hoc tests, respectively. Chi-square or Fisher's exact tests will be used for categorical variables, and repeated measures ANOVA for time-dependent hemodynamic changes. A p value \< 0.05 will be considered statistically significant.

02

Conditions studied

  • Hypotension After Neuraxial Anesthesia
  • Cesarean Section
  • Anesthesia, Obstetrical
  • Post-Dural Puncture Headache

Keywords

  • Dural Puncture Epidural
  • Spinal Anesthesia
  • Epidural Anesthesia
  • Maternal Hemodynamics
  • Shock Index
  • Vasopressor
  • Block Onset Time
  • Block Quality
  • Apgar Score
03

In context

Post-Dural Puncture Headache

128 studies on the registry are indexed under Post-Dural Puncture Headache; 26 are open to participants now.

This study's planned enrollment of 120 is above the median of 80 across 85 interventional studies indexed under Post-Dural Puncture Headache.

Browse Post-Dural Puncture Headache studies →

Lead sponsor

Bursa Yuksek Ihtisas Training and Research Hospital is the lead sponsor of 50 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women aged 18 years or older
  • American Society of Anesthesiologists (ASA) physical status II (uncomplicated pregnancy without systemic disease)
  • Term pregnancy (37-40 weeks of gestation)
  • Singleton pregnancy
  • Scheduled for elective cesarean delivery
  • No contraindication to neuraxial anesthesia
  • Voluntary participation with signed written informed consent

Exclusion criteria

Exclusion Criteria:

  • Local infection at the puncture site, coagulopathy (bleeding diathesis), or thrombocytopenia (platelet count \< 100,000/mm3)
  • Severe scoliosis or history of major spinal surgery
  • Multiple pregnancy
  • History of preeclampsia, eclampsia, or gestational hypertension
  • Chronic systemic disease (diabetes mellitus, chronic kidney disease, or cardiac disease)
  • Body mass index (BMI) of 40 kg/m2 or higher
  • Fetal distress or placental abnormalities (placenta previa, placental abruption, etc.)
  • Height less than 150 cm or more than 180 cm
  • Inability to communicate, neurological or psychiatric disease, or refusal to give consent
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Spinal Anesthesia

    Participants will receive spinal anesthesia with intrathecal 10 mg of 0.5% hyperbaric bupivacaine plus 10 mcg fentanyl.

    Procedure: Spinal Anesthesia

  • Active comparator
    Epidural Anesthesia

    Participants will receive epidural anesthesia. After epidural catheter placement and a test dose, 15-20 mL of local anesthetic solution (10 mL 0.5% isobaric bupivacaine + 50 mcg fentanyl + 5 mL 2% lidocaine + 4 mL normal saline) will be administered. If bilateral T6 sensory block is not achieved within 10 minutes, 5 mL of 0.25% bupivacaine will be given every 5 minutes up to a cumulative maximum of 30 mL.

    Procedure: Epidural Anesthesia

  • Active comparator
    Dural Puncture Epidural Anesthesia

    Participants will receive dural puncture epidural anesthesia. The dura will be punctured with a 27G spinal needle without intrathecal drug injection, followed by epidural catheter placement, a test dose, and the same epidural regimen as the Epidural Anesthesia arm (15-20 mL of 10 mL 0.5% isobaric bupivacaine + 50 mcg fentanyl + 5 mL 2% lidocaine + 4 mL normal saline; additional 5 mL of 0.25% bupivacaine every 5 minutes up to 30 mL if bilateral T6 block is not achieved within 10 minutes).

    Procedure: Dural Puncture Epidural Anesthesia

Interventions

  • ProcedureSpinal Anesthesia

    Single-shot intrathecal injection of 10 mg 0.5% hyperbaric bupivacaine plus 10 mcg fentanyl.

  • ProcedureEpidural Anesthesia

    Epidural catheter placement followed by incremental administration of local anesthetic and fentanyl through the catheter.

  • ProcedureDural Puncture Epidural Anesthesia

    Dural puncture with a 27G spinal needle without intrathecal drug injection, followed by epidural catheter placement and administration of local anesthetic and fentanyl through the catheter.

06

What researchers measure

Primary outcomes

  1. Incidence of Maternal Hypotension

    Proportion of participants who develop at least one episode of hypotension, defined as a decrease in mean arterial pressure of more than 20% from baseline or systolic blood pressure below 90 mmHg. Baseline values are recorded before the neuraxial block. Blood pressure will be measured non-invasively every 3 minutes for the first 20 minutes after completion of the block and every 5 minutes thereafter until the end of surgery.

    Time frame: From completion of the neuraxial block (time 0) until the end of surgery (approximately 90 minutes)

Secondary outcomes

  1. Number of Hypotension Episodes

    Number of hypotension episodes per participant (count), using the same definition as the primary outcome.

    Time frame: From completion of the neuraxial block until the end of surgery (approximately 90 minutes)

  2. Total Ephedrine Consumption

    Total dose of intravenous ephedrine administered to treat hypotension, in milligrams (mg).

    Time frame: From completion of the neuraxial block until the end of surgery (approximately 90 minutes)

  3. Shock Index

    Ratio of heart rate to systolic blood pressure (unitless ratio).

    Time frame: Baseline (before the block), every 3 minutes for the first 20 minutes after completion of the block, and every 5 minutes thereafter until the end of surgery (approximately 90 minutes)

  4. Diastolic Shock Index

    Ratio of heart rate to diastolic blood pressure (unitless ratio)

    Time frame: Baseline (before the block), every 3 minutes for the first 20 minutes after completion of the block, and every 5 minutes thereafter until the end of surgery (approximately 90 minutes)

  5. Time to T6 Sensory Block

    Time from the end of local anesthetic injection to bilateral T6 sensory block, assessed by pin-prick and cold tests, in minutes.

    Time frame: From completion of the neuraxial block until bilateral T6 sensory block is achieved

  6. Umbilical Cord Blood pH

    pH of umbilical cord blood measured by blood gas analysis (pH units).

    Time frame: At delivery

  7. Incidence of Post-Dural Puncture Headache

    Proportion of participants with post-dural puncture headache, assessed in the hospital at postoperative 24 hours and by telephone on postoperative day 3.

    Time frame: Postoperative 24 hours and postoperative day 3

07

Study locations

1 site
  • Bursa Yuksek Ihtisas Training and Research Hospital
    Bursa, Yıldırım, Turkey (Türkiye)
    • Ummu Nur Bulut Ergun, MD · Contact · buluttummunur@gmail.com · +905544738733
    • Derya Karasu, MD, Prof. · Principal investigator
    • Ummu Nur Bulut Ergun, MD · Sub investigator
08

References and documents

Publications

  • Wang SY, He Y, Zhu HJ, Han B. Dural puncture epidural technique provides better anesthesia quality in repeat cesarean delivery than epidural technique: Randomized controlled study. World J Clin Cases. 2022 Jul 16;10(20):6890-6899. doi: 10.12998/wjcc.v10.i20.6890. PubMed 36051113 ↗
  • Rao WY, Xu F, Dai SB, Mei Z, Chen XP, Lv CC, Liu CL, Ngan Kee W, Chen XZ. Comparison of Dural Puncture Epidural, Epidural and Combined Spinal-Epidural Anesthesia for Cesarean Delivery: A Randomized Controlled Trial. Drug Des Devel Ther. 2023 Jul 18;17:2077-2085. doi: 10.2147/DDDT.S415684. eCollection 2023. PubMed 37484190 ↗
  • Zhou S, Cao X, Zhou Y, Xu Z. Comparison of Surgical Anesthesia Onset Between Dural-Puncture Epidural and Standard Epidural Techniques for Emergency Cesarean Section: Protocol for a Randomized Controlled Trial. J Pain Res. 2025 May 16;18:2509-2519. doi: 10.2147/JPR.S514780. eCollection 2025. PubMed 40395936 ↗
  • Wu Q, Gan Y, Zhao Z, Luo C, Liu X, Wang B. The Effectiveness and Safety of Dural Puncture Epidural for Aged Patients Undergoing Orthopedic Surgery: A Randomized Controlled Trial. Clin Interv Aging. 2026 Jan 12;21:561324. doi: 10.2147/CIA.S561324. eCollection 2026. PubMed 41859290 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared because participants did not provide consent for data sharing beyond the study team.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883733
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Responsible party
Ümmü Nur Bulut Ergün (Resident Physician, Department of Anesthesiology and Reanimation, Bursa Yuksek Ihtisas Training and Research Hospital) — Principal investigator
First posted
Oct 20, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Oct 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Oct 20, 2026

Study contacts

Ümmü Nur Bulut Ergün, MD
Contact
buluttummunur@gmail.com
+905544738733
Derya Karasu, MD, Prof.
principal investigator · Bursa Yuksek Ihtisas Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion